Skip to main content

Advertisement

SpringerLink
Log in

Lifestyle and sociodemographic factors associated with treatment choice of clinically localized prostate cancer in an equal access healthcare system

  • Brief Communication
  • Clinical Research
  • Published:
Prostate Cancer and Prostatic Diseases Submit manuscript

Abstract

Sociodemographic and lifestyle factors may play a role in determining whether patients with clinically localized prostate cancer (PC) are managed with active surveillance (AS), radical prostatectomy (RP), or radiation therapy (RT); however, these relationships have not been well examined. In a cross-sectional study conducted within an equal access healthcare system, multivariable adjusted regression analysis revealed that living with a spouse or partner was associated with a 65% lower chance of being managed by RT (P = 0.001) and 57% lower risk of being managed by AS (P = 0.042) compared with RP. No other sociodemographic or lifestyle factors were independently associated with treatment modality.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Data availability

Data available, within VA rules and policy requirements, upon request.

References

  1. Yap ML, O’Connell DL, Goldsbury DE, Weber MF, Smith DP, Barton MB. Patterns of care for men with prostate cancer: the 45 and Up Study. Med J Aust. 2021;214:271–8.

    Article  Google Scholar 

  2. Chierigo F, Wenzel M, Wurnschimmel C, Simone Flammia R, Horlemann B, Tian Z, et al. Survival after radical prostatectomy versus radiation therapy in high-risk and very high-risk prostate cancer. J Urol. 2022;207:375–84.

    Article  Google Scholar 

  3. Antonelli A, Palumbo C, Noale M, Artibani W, Bassi P, Bertoni F, et al. Overview of potential determinants of radical prostatectomy versus radiation therapy in management of clinically localized prostate cancer: results from an Italian, prospective, observational study (the Pros-IT CNR study). Minerva Urol Nefrol. 2020;72:595–604.

    Article  Google Scholar 

  4. Denberg TD, Beaty BL, Kim FJ, Steiner JF. Marriage and ethnicity predict treatment in localized prostate carcinoma. Cancer. 2005;103:1819–25.

    Article  Google Scholar 

  5. Schymura MJ, Kahn AR, German RR, Hsieh MC, Cress RD, Finch JL, et al. Factors associated with initial treatment and survival for clinically localized prostate cancer: results from the CDC-NPCR Patterns of Care Study (PoC1). BMC Cancer. 2010;10:152.

    Article  Google Scholar 

  6. Yan Y, Carvalhal GF, Catalona WJ, Young JD. Primary treatment choices for men with clinically localized prostate carcinoma detected by screening. Cancer. 2000;88:1122–30.

    Article  CAS  Google Scholar 

  7. Sayyid RK, Klotz L, Benton JZ, Lodh A, Lambert JH, Woodruff P, et al. Influence of sociodemographic factors on definitive intervention among low-risk active surveillance patients. Urology. 2021;155:117–23.

    Article  Google Scholar 

  8. Charles C, Gafni A, Whelan T. Decision-making in the physician-patient encounter: revisiting the shared treatment decision-making model. Soc Sci Med. 1999;49:651–61.

    Article  CAS  Google Scholar 

  9. O’Rourke ME. Narrowing the options: the process of deciding on prostate cancer treatment. Cancer Invest. 1999;17:349–59.

    Article  Google Scholar 

  10. Chen ZH, Yang KB, Zhang YZ, Wu CF, Wen DW, Lv JW, et al. Assessment of modifiable factors for the association of marital status with cancer-specific survival. JAMA Netw Open. 2021;4:e2111813.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, CA, USA

    Eric M. Anderson, Christopher J. Gay, Diana J. Lu & Zachary S. Zumsteg

  2. Durham Veterans Affairs Health Care System, Durham, NC, USA

    Lin Gu, Taofik Oyekunle, Amanda M. De Hoedt, Emily Wiggins & Stephen J. Freedland

  3. Duke Cancer Institute, Biostatistics Shared Resource, Durham, NC, USA

    Lin Gu & Taofik Oyekunle

  4. Division of Urology, Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA, USA

    Timothy J. Daskivich, Stephen J. Freedland & Ilona Csizmadi

  5. Center for Integrated Research on Cancer and Lifestyle, Cedars-Sinai Medical Center, Los Angeles, CA, USA

    Stephen J. Freedland & Ilona Csizmadi

Authors
  1. Eric M. Anderson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lin Gu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Taofik Oyekunle
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Amanda M. De Hoedt
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Emily Wiggins
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Christopher J. Gay
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Diana J. Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Timothy J. Daskivich
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Stephen J. Freedland
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Zachary S. Zumsteg
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Ilona Csizmadi
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

EMA: Conceptualization, writing–original draft and writing–review and editing. LG: Formal analysis, writing–review, and editing. TO: Formal analysis, writing–review, and editing. AMDH: Methodology, data collection, writing–review, and editing. EW: Methodology, data collection, writing–review, and editing. CJG: Writing–review, and editing. DJL: Writing–review, and editing. TJD: Methodology, writing–review, and editing. SJF: Conceptualization, methodology, data collection, supervision, writing–review, and editing. ZSZ: Conceptualization, methodology, supervision, writing–original draft, and writing–review and editing. IC: Conceptualization, methodology, supervision, writing–original draft, and writing–review and editing.

Corresponding author

Correspondence to Eric M. Anderson.

Ethics declarations

Competing interests

The authors have no conflicts of interest related to this work. ZSZ was on the external advisory board for the Scripps Proton Therapy Center and has consulted for EMD Serono. ZSZ’s spouse does legal work for Johnson and Johnson and Allergan through her law firm. All other authors have no disclosures.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Anderson, E.M., Gu, L., Oyekunle, T. et al. Lifestyle and sociodemographic factors associated with treatment choice of clinically localized prostate cancer in an equal access healthcare system. Prostate Cancer Prostatic Dis 25, 593–595 (2022). https://doi.org/10.1038/s41391-022-00551-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41391-022-00551-4

  • Springer Nature Limited

Search

Navigation